U.S. jury says Bayer must pay $80 million to man in Roundup cancer trial
SAN FRANCISCO/NEW YORK (Reuters) - A U.S. jury on Wednesday awarded $80 million to a man who claimed his use of Bayer AG’s glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.
The jury in San Francisco federal court said the company was liable for plaintiff Edwin Hardeman’s non-Hodgkin’s lymphoma.
NewsOK highlights articles of interest from selected websites to increase the scope of commentary and coverage available to readers. Readers are linked back to the source of the content.